Q&A: Renier Brentjens on Obstacles and Opportunities in CAR T-cell Therapy

Renier Brentjens, MD, PhD, a pioneer of chimeric antigen receptor (CAR) T-cell therapy, speaks about his early work in the field, the current limitations of CAR T cells, and how researchers might advance the technology in the coming years.